Hazard ratio | 95% CI | p Value | ||
---|---|---|---|---|
Lower | Upper | |||
*Higher pretreatment fibrosis stage associated with a smaller chance of fibrosis progression, while older age† and biochemical response‡ were associated with a higher chance of fibrosis progression. | ||||
Male sex | 0.02 | −0.29 | 0.34 | 0.86 |
Age | 0.29† | 0.00 | 0.03 | 0.01 |
Fibrosis stage pretreatment | −0.50* | −0.52 | −0.21 | <0.01 |
Activity score pretreatment | 0.09 | −0.04 | 0.12 | 0.37 |
Time between biopsies | 0.08 | −0.12 | 0.29 | 0.40 |
Biochemical response to therapy v sustained virological response | 0.31‡ | 0.30 | 1.49 | <0.01 |